Search research articles
Contact Us
Filters
Showing results (221-230 of 343) with videos related to
Page
of 35
Sort By:
Nature Reviews. Clinical Oncology
|
November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
Michele D Stanchina, Skye Montoya, Alexey V Danilov, et al.
Blood Advances
|
August 22, 2020
Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up
Jorge J Castillo, Kirsten Meid, Catherine A Flynn, et al.
British Journal of Haematology
|
November 22, 2018
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib
Matthew P Cheng, Amanda E Kusztos, Joshua N Gustine, et al.
American Journal of Hematology
|
February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study
Jorge J Castillo, Brady E Beltran, Michele Bibas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2016
Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)
Steven P Treon, Kirsten Meid, Christina Tripsas, et al.
British Journal of Haematology
|
February 28, 2020
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia
Cristina Jiménez, Gloria G Chan, Lian Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2020
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
Steven P Treon, Kirsten Meid, Joshua Gustine, et al.
Blood
|
July 22, 2021
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
Marit Jalink, Sigbjørn Berentsen, Jorge J Castillo, et al.
Cancer
|
April 19, 2012
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy
Jorge J Castillo, Michael Furman, Brady E Beltrán, et al.
Blood Advances
|
September 21, 2020
Comparative genomics of CXCR4MUT and CXCR4WT single cells in Waldenström's macroglobulinemia
Cristina Jiménez, Lian Xu, Nickolas Tsakmaklis, et al.
Page
of 35
Search research articles
Search
Showing results (221-230 of 343) with videos related to
Sort By:
Page
of 35
Nature Reviews. Clinical Oncology
|
November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
Michele D Stanchina, Skye Montoya, Alexey V Danilov, et al.
Blood Advances
|
August 22, 2020
Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up
Jorge J Castillo, Kirsten Meid, Catherine A Flynn, et al.
British Journal of Haematology
|
November 22, 2018
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib
Matthew P Cheng, Amanda E Kusztos, Joshua N Gustine, et al.
American Journal of Hematology
|
February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study
Jorge J Castillo, Brady E Beltran, Michele Bibas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2016
Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)
Steven P Treon, Kirsten Meid, Christina Tripsas, et al.
British Journal of Haematology
|
February 28, 2020
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia
Cristina Jiménez, Gloria G Chan, Lian Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2020
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
Steven P Treon, Kirsten Meid, Joshua Gustine, et al.
Blood
|
July 22, 2021
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
Marit Jalink, Sigbjørn Berentsen, Jorge J Castillo, et al.
Cancer
|
April 19, 2012
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy
Jorge J Castillo, Michael Furman, Brady E Beltrán, et al.
Blood Advances
|
September 21, 2020
Comparative genomics of CXCR4MUT and CXCR4WT single cells in Waldenström's macroglobulinemia
Cristina Jiménez, Lian Xu, Nickolas Tsakmaklis, et al.
Page
of 35